MYCELEX-7 COMBINATION PACK Drug Patent Profile
✉ Email this page to a colleague
When do Mycelex-7 Combination Pack patents expire, and what generic alternatives are available?
Mycelex-7 Combination Pack is a drug marketed by Bayer Healthcare Llc and is included in one NDA.
The generic ingredient in MYCELEX-7 COMBINATION PACK is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mycelex-7 Combination Pack
A generic version of MYCELEX-7 COMBINATION PACK was approved as clotrimazole by P AND L on July 16th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYCELEX-7 COMBINATION PACK?
- What are the global sales for MYCELEX-7 COMBINATION PACK?
- What is Average Wholesale Price for MYCELEX-7 COMBINATION PACK?
Summary for MYCELEX-7 COMBINATION PACK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Clinical Trials: | 3 |
| Patent Applications: | 3,346 |
| DailyMed Link: | MYCELEX-7 COMBINATION PACK at DailyMed |
Recent Clinical Trials for MYCELEX-7 COMBINATION PACK
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Weill Medical College of Cornell University | Phase 4 |
| Onxeo | Phase 3 |
| Boehringer Ingelheim | Phase 3 |
US Patents and Regulatory Information for MYCELEX-7 COMBINATION PACK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare Llc | MYCELEX-7 COMBINATION PACK | clotrimazole | CREAM, TABLET;TOPICAL, VAGINAL | 020389-002 | Jun 23, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
